Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Waller

Showing results (221-230 of 226) with videos related to

Pageof 23
Sort By:
You have reached the last page of results.This site can display upto 226 results.
Reproductive Toxicology (Elmsford, N.Y.)|October 6, 1997
Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanismsL E Gray, W R Kelce, T Wiese, et al.
Leukemia|January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Leukemia|October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-CM C Müller, N Gattermann, T Lahaye, et al.
Leukemia|January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Pneumologie (Stuttgart, Germany)|December 8, 2022
[German S1 Guideline Long-/Post-COVID]A R Koczulla, T Ankermann, U Behrends, et al.
Vox Sanguinis|May 1, 2010
Inventory managementD V Devine, G D Sher, H W Reesink, et al.
Pageof 23

Showing results (221-230 of 226) with videos related to

Sort By:
Pageof 23
You have reached the last page of results.This site can display upto 226 results.
Reproductive Toxicology (Elmsford, N.Y.)|October 6, 1997
Endocrine Screening Methods Workshop report: detection of estrogenic and androgenic hormonal and antihormonal activity for chemicals that act via receptor or steroidogenic enzyme mechanismsL E Gray, W R Kelce, T Wiese, et al.
Leukemia|January 12, 2017
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Leukemia|October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-CM C Müller, N Gattermann, T Lahaye, et al.
Leukemia|January 31, 2018
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLC Schütz, S Inselmann, S Saussele, et al.
Pneumologie (Stuttgart, Germany)|December 8, 2022
[German S1 Guideline Long-/Post-COVID]A R Koczulla, T Ankermann, U Behrends, et al.
Vox Sanguinis|May 1, 2010
Inventory managementD V Devine, G D Sher, H W Reesink, et al.
Pageof 23